| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 992,600 | 1,030,200 | 952,200 | 1,079,500 | | Cost of Revenue | 230,300 | 243,100 | 237,200 | 262,300 | | | Gross Profit | 762,300 | 787,100 | 715,000 | 817,200 | | | Operating Expenses | | Research Development | 51,800 | 47,200 | 46,700 | 50,100 | | Selling General and Administrative | 430,700 | 435,600 | 404,900 | 446,200 | | Non Recurring |
-
| 64,600 | 53,100 | 12,500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 279,800 | 239,700 | 210,300 | 308,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (4,200) | 28,200 | 6,800 | | Earnings Before Interest And Taxes | 279,800 | 235,500 | 238,500 | 315,200 | | Interest Expense | 3,700 |
-
|
-
|
-
| | Income Before Tax | 276,100 | 235,500 | 238,500 | 315,200 | | Income Tax Expense | 73,900 | 67,900 | 23,500 | 87,800 | | Minority Interest |
-
| (100) | (300) | (300) | | | | Net Income From Continuing Ops | 202,200 | 167,500 | 214,700 | 227,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 202,200 | 167,500 | 214,700 | 227,100 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $202,200 | $167,500 | $214,700 | $227,100 |
|
0.45% Nasdaq 
0.20%
Income Statement
